Return to site

Swiss Rockets AG signs exclusive agreement with Gigabases Switzerland AG to develop a novel Vaccine for COVID-19 based on Gigabases breakthrough DNA technology

Swiss Rockets AG (“Swiss Rockets”) entered an exclusive partnership with Gigabases Switzerland AG (“Gigabases”). Swiss Rockets took over the entire Covid-19 vaccine candidate suite “COVAX” from Gigabases which was developed by our R&D-Team during the last months. This will allow Swiss Rockets to further develop a novel vaccine against Covid-19. More news to come soon!

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OK